Anti-tumor necrosis factor agents and COVID-19: A word of caution.
作者信息
Hajjar Roy, Chan Gabriel
机构信息
Department of Surgery, Hôpital Maisonneuve-Rosemont, Montréal, Québec, Canada. 5415, boulevard de l'Assomption, Montréal, Québec, Canada.
Division of General Surgery, Université de Montréal, Montréal, Québec, Canada.
出版信息
J Clin Transl Res. 2020 Aug 29;6(3):94-96. eCollection 2020 Sep 5.
Abstract
摘要
相似文献
1
Anti-tumor necrosis factor agents and COVID-19: A word of caution.抗肿瘤坏死因子药物与新型冠状病毒肺炎：需谨慎对待
J Clin Transl Res. 2020 Aug 29;6(3):94-96. eCollection 2020 Sep 5.
2
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.肿瘤坏死因子诱导性关节炎中肿瘤坏死因子、白细胞介素-1和RANKL通路的单一及联合抑制：对滑膜炎症、骨侵蚀和软骨破坏的影响
Arthritis Rheum. 2004 Jan;50(1):277-90. doi: 10.1002/art.11487.
3
Exposure to Anti-tumor Necrosis Factor Medications Increases the Incidence of Pouchitis After Restorative Proctocolectomy in Patients With Ulcerative Colitis.抗肿瘤坏死因子药物的暴露会增加溃疡性结肠炎患者直肠结肠切除术后 pouchitis 的发生率。
Dis Colon Rectum. 2019 Nov;62(11):1344-1351. doi: 10.1097/DCR.0000000000001467.
4
Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis.类风湿关节炎患者接受 TNF 拮抗剂治疗的非黑素瘤皮肤癌风险：系统评价和荟萃分析。
Clin Rheumatol. 2020 Mar;39(3):769-778. doi: 10.1007/s10067-019-04865-y. Epub 2019 Dec 10.
5
B cell depletion may be more effective than switching to an alternative anti-tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti-tumor necrosis factor agents.对于对抗肿瘤坏死因子药物反应不足的类风湿关节炎患者，B细胞耗竭可能比换用另一种抗肿瘤坏死因子药物更有效。
Arthritis Rheum. 2007 May;56(5):1417-23. doi: 10.1002/art.22520.
6
Tumor necrosis factor inhibitors block apoptosis of human epithelial cells of the salivary glands.肿瘤坏死因子抑制剂可阻断唾液腺人类上皮细胞的凋亡。
Ann N Y Acad Sci. 2009 Aug;1171:407-14. doi: 10.1111/j.1749-6632.2009.04688.x.
7
Molecular design of conjugated tumor necrosis factor-alpha: synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis factor-alpha.共轭肿瘤坏死因子-α的分子设计：聚乙烯吡咯烷酮修饰的肿瘤坏死因子-α的合成与特性
Biochem Biophys Res Commun. 1999 Apr 13;257(2):448-53. doi: 10.1006/bbrc.1999.0353.
8
Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.低疾病活动度类风湿关节炎患者肿瘤坏死因子阻断剂的减量和停药策略
Cochrane Database Syst Rev. 2014 Sep 29(9):CD010455. doi: 10.1002/14651858.CD010455.pub2.
9
Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy.接受抗肿瘤坏死因子（TNF）-α治疗的风湿病患者的妊娠情况。
Rheumatology (Oxford). 2007 Apr;46(4):695-8. doi: 10.1093/rheumatology/kel400. Epub 2006 Dec 7.
10
Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and/or sacroiliitis who were resistant to colchicine treatment.肿瘤坏死因子拮抗剂治疗对秋水仙碱治疗抵抗的伴有慢性关节炎和/或骶髂关节炎的家族性地中海热患者的疗效。
J Clin Rheumatol. 2011 Oct;17(7):358-62. doi: 10.1097/RHU.0b013e31823682f5.
引用本文的文献
1
Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review.2019 年冠状病毒病（COVID-19）的口面粘膜皮肤表现：系统评价。
PLoS One. 2022 Jun 1;17(6):e0265531. doi: 10.1371/journal.pone.0265531. eCollection 2022.
本文引用的文献
1
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19.炎症性肠病中的抗TNF-α药物与COVID-19病程
Inflamm Bowel Dis. 2020 Jun 18;26(7):e73. doi: 10.1093/ibd/izaa114.
2
Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.TNF 拮抗剂在老年溃疡性结肠炎患者中的安全性和疗效：来自随机试验的患者水平汇总分析数据。
Clin Gastroenterol Hepatol. 2021 May;19(5):939-946.e4. doi: 10.1016/j.cgh.2020.04.070. Epub 2020 May 1.
3
Characteristics and Prognosis of Patients With Inflammatory Bowel Disease During the SARS-CoV-2 Pandemic in the Basque Country (Spain).西班牙巴斯克地区新冠疫情期间炎症性肠病患者的特征与预后
Gastroenterology. 2020 Aug;159(2):781-783. doi: 10.1053/j.gastro.2020.04.043. Epub 2020 Apr 21.
4
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.武汉成人 COVID-19 住院患者严重程度和死亡率的危险因素。
J Allergy Clin Immunol. 2020 Jul;146(1):110-118. doi: 10.1016/j.jaci.2020.04.006. Epub 2020 Apr 12.
5
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.迫切需要开展针对新型冠状病毒肺炎的抗肿瘤坏死因子疗法试验。
Lancet. 2020 May 2;395(10234):1407-1409. doi: 10.1016/S0140-6736(20)30858-8. Epub 2020 Apr 9.
6
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
7
Increased Discontinuation Rates of Anti-TNF Therapy in Elderly Inflammatory Bowel Disease Patients.老年炎症性肠病患者抗 TNF 治疗的停药率增加。
J Crohns Colitis. 2020 Jul 30;14(7):888-895. doi: 10.1093/ecco-jcc/jjaa012.
8
Anti-TNFα therapy in inflammatory lung diseases.抗 TNF-α 治疗在炎症性肺疾病中的应用。
Pharmacol Ther. 2017 Dec;180:90-98. doi: 10.1016/j.pharmthera.2017.06.008. Epub 2017 Jun 19.
9
Risk for Overall Infection with Anti-TNF and Anti-integrin Agents Used in IBD: A Systematic Review and Meta-analysis.炎症性肠病中使用抗TNF和抗整合素药物导致总体感染的风险：一项系统评价和荟萃分析。
Inflamm Bowel Dis. 2017 Apr;23(4):570-577. doi: 10.1097/MIB.0000000000001049.
10
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.类风湿关节炎、银屑病关节炎和强直性脊柱炎中使用抗TNF药物的感染风险：一项系统评价和荟萃分析。
Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34. doi: 10.1080/14740338.2016.1240783.
Zotero 插件